MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.avsg.2015.04.092

Медицинская библиотека · Annals of vascular surgery · 2015

Mortality and Cost of Acute and Chronic Kidney Disease after Vascular Surgery.

Huber Matthew, Ozrazgat-Baslanti Tezcan, Thottakkara Paul, Efron Philip A, Feezor Robert, Hobson Charles, Bihorac Azra

СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

Both acute kidney injury (AKI) and chronic kidney disease (CKD) are common yet underappreciated risk factors for adverse perioperative outcomes. We hypothesize that AKI and CKD are associated with similar increases in 90-day mortality and cost in patients undergoing major vascular surgery.

METHODS

We used multivariable regression analyses to evaluate the associations between AKI and CKD and incremental 90-day mortality and hospital cost in a single-center cohort of 3646 adult patients undergoing major vascular surgery. We defined AKI using Kidney Disease: Improving Global Outcomes criteria as change in creatinine ≥ 0.3 mg/dL or ≥ 50% increase from the reference value. CKD was determined from medical history. Regression models were adjusted for demographic and socioeconomic characteristics, comorbid conditions, surgery type, and postoperative complications.

RESULTS

The prevalence of kidney disease among vascular surgery patients is high with 49% of patients developing AKI during hospitalization and 17% presenting with CKD on admission. In risk-adjusted logistic regression analysis, perioperative AKI (odds ratio 2.2, 95% confidence interval 1.5-3.3) was the most significant predictor of 90-day mortality. The risk-adjusted average cost was significantly higher for patients with any type of kidney disease. The incremental cost of having any type of kidney disease ranged from $9100 to $19,100, even after adjustment for underlying comorbidities and other postoperative complications.

CONCLUSIONS

Kidney disease after major vascular surgery is associated with significant increases in 90-day mortality and cost with the highest risk observed among patients with AKI regardless of previous CKD.

Для цитирования: Huber Matthew, Ozrazgat-Baslanti Tezcan, Thottakkara Paul, Efron Philip A, Feezor Robert, Hobson Charles, Bihorac Azra. Mortality and Cost of Acute and Chronic Kidney Disease after Vascular Surgery.. Annals of vascular surgery. 2015. DOI: 10.1016/j.avsg.2015.04.092.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.